Kristen Nields

Kristen Nields currently works at Janssen Biopharmaceuticals in cell line development supporting biophysical characterization of new cell lines for development, and innovative technology to support high throughput characterization. She holds a PhD in analytical chemistry from the University of Sciences and over 20 years of experience in the pharmaceutical industry. She began her career at Janssen in 2002 where she helped develop FIH metabolite ID methods by LC/MS to support DMPK, transitioning to Merck and then to GSK supervising a biopharma bioanalytical team overseeing multiple technologies and providing oversight as the analytical lead for multiple CMC projects, joining Janssen again in 2014.